J2 Capital Management Inc

Position in ABBV — AbbVie Inc.

CIK 1586882 TROY, MI

Position in ABBV

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,817,847

New position

Shares Held

7,224

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

4.05%

of 13F equity value

Holder Rank

#2,038

of 4,153 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

J2 Capital Management Inc holds $5,355,034 across 6 Drug Manufacturers - General names. ABBV ranks #1 (33.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	7,224	$1,817,847
2	LLY	ELI LILLY & Co	824	$988,330
3	MRK	Merck & Co., Inc.	6,147	$789,889
4	JNJ	Johnson & Johnson	2,765	$702,227
5	GSK	GSK plc	11,338	$594,337
6	GILD	Gilead Sciences, Inc.	3,660	$462,404

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,817,847	7,224	—	Shares	Sole	2026-07-20
No filing history on record for this holder in this stock.